IVIG (Gamunex-C) Treatment Study for POTS Subjects

Summary

The purpose of this trial is to evaluate the symptomatic benefits of immunomodulatory treatment with IVIG for POTS (postural tachycardia syndrome) patients with evidence of autoimmunity.

Timeline

Start

2018-10-29

Primary completion

2023-06-26

Completion

2023-12-01

Publications

• Background Goodman BP, Crepeau A, Dhawan PS, Khoury JA, Harris LA. Spectrum of Autonomic Nervous System Impairment in Sjogren Syndrome. Neurologist. 2017 Jul;22(4):127-130. doi: 10.1097/NRL.0000000000000134.

Drugs

Indications